Dr. Ali Es-haghi, the Director General of the Razi Institute, emphasized the institute's significant scientific and social contributions, underscoring its importance as a crucial national asset that must be preserved and enhanced. He noted that the Razi Institute is the region's largest scientific and research organization dedicated to vaccine and biological product development.

In his address, Dr. Es-haghi highlighted the institute's century-long commitment to public health and safety, a legacy that is increasingly recognized by the public. He stressed the importance of effectively communicating the institute's significance and achievements to both national and international audiences.

Founded on January 6, 1925, in response to the devastating Rinderpest pandemic, the Razi Institute has been a pioneer in vaccine and serum production in Iran. Today, it offers a diverse portfolio of over 80 biological products, reflecting years of dedicated research and innovation by its scientists.

The Razi Institute operates six branches across Iran—in Mashhad, Ahvaz, Shiraz, Kerman, Marand, and Arak—ensuring that local vaccine production and research needs are met, with its main facility located in Karaj. As the institute celebrates this significant milestone, it reflects on a century of service to public health and anticipates future advancements in vaccine development.